Glenmark Pharmaceuticals
GLENMARK.NS
$12.73
Share price
-0.79%
Change (1 day)
84.76%
Change (1 year)
Categories
Glenmark Pharmaceuticals (GLENMARK.NS) - Cash on Hand
Cash on Hand as of September 2023 : $0.16 B
According to Glenmark Pharmaceuticals
's latest financial reports the company has $0.16 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Glenmark Pharmaceuticals - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-03-31 | $0.17 B | -6.36% |
| 2022-03-31 | $0.19 B | 15.11% |
| 2021-03-31 | $0.16 B | 5.67% |
| 2020-03-31 | $0.15 B | -4.12% |
| 2019-03-31 | $0.16 B | -24.78% |
| 2018-03-31 | $0.21 B | 15.76% |
| 2017-03-31 | $0.18 B | 45.13% |
| 2016-03-31 | $0.12 B | 4.23% |
| 2015-03-31 | $0.12 B | -8.42% |
| 2014-03-31 | $0.13 B | 19.49% |
| 2013-03-31 | $0.11 B | 74.02% |
| 2012-03-31 | $65.06 M | 48.95% |
| 2011-03-31 | $43.68 M | 82.86% |
| 2010-03-31 | $23.88 M | 69.71% |
| 2009-03-31 | $14.07 M | -64.13% |
| 2008-03-31 | $39.23 M | 60.18% |
| 2007-03-31 | $24.49 M | 3.29% |
| 2006-03-31 | $23.71 M | -18.74% |
| 2005-03-31 | $29.18 M | 1456.46% |
| 2004-03-31 | $1.87 M |